Day: March 14, 2024

Company Announcement no. 147 – 2024Copenhagen, March 14th, 2024 2023 Annual Report – 25% revenue growth in 2023, expecting group profitability in 2024 In 2023, GreenMobility initiated a focus on market consolidation to focus on markets that are profitable or have a clear outlook to become profitable on short-term. Consequently, GreenMobility has closed or is planning to close international markets to focus on its core Danish market where GreenMobility today is a market leader. GreenMobility’s ambition is to become the first European electric vehicle operator to be profitable and thereby supporting the green transition in mobility. The main focus for 2024 is therefore to reach group profitability, which the management and board is determined to reach. Key highlights of 2023:Group revenue of DKK 94.6 million which is a 25% growth compared...

MONTRÉAL, March 14, 2024 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) announces that it has filed an addendum to its management proxy circular dated February 23, 2024 for the annual and special meeting of shareholders to be held in Montreal, Québec on April 3, 2024. The addendum is available on IBEX’s website at www.ibex.ca and under IBEX’s profile on SEDAR+ at www.sedarplus.ca. The addendum provides that the proposed amalgamation (the “Amalgamation”) of IBEX and 15720273 Canada Inc. (the “Purchaser”), a newly-incorporated, wholly-owned subsidiary of BBI Solutions OEM Limited (“BBI”), whereby BBI will acquire all of the issued and outstanding shares of IBEX at a price of $1.45 per share in cash, must be approved by a “majority of the minority” vote under Multilateral Instrument 61-101 Protection...

Company Announcement Copenhagen, 14 March 2024 No. 9/2024 Notice to convene the Annual General Meeting of ISS A/S ISS A/S, a leading workplace experience and facility management company, today announces that the Annual General Meeting of ISS A/S will be held on Thursday 11 April 2024 at 11:00 (CEST) at ISS Facility Services A/S, Gyngemose Parkvej 50, DK-2860 Søborg, Denmark The notice to convene the Annual General Meeting (including Appendix 1) is enclosed. Further information about the Annual General Meeting is available athttps://www.issworld.com/en/investor/investor-relations/corporate-governance/annual-general-meeting For investor enquiries Jacob Johansen, Head of Group Investor Relations, +45 21 69 35 91 Kristian Tankred, Senior Investor Relations Manager, +45 30 67 35 25 For media enquiries Charlotte Holm, Head of External Communication,...

Company announcementfor ROCKWOOL A/SRelease no. 11 – 2024to Nasdaq Copenhagen 14 March 2024 NOTICE CONVENING THE ANNUAL GENERAL MEETING OF ROCKWOOL A/S The annual general meeting of shareholders is hereby convened to take place on Wednesday, 10 April 2024 at 3:00 p.m. at Roskilde Kongrescenter, Møllehusvej 15, DK-4000 Roskilde, Denmark. Registration for the general meeting must take place no later than Friday, 5 April 2024 either electronically via the shareholder portal on www.rockwool.com/group/shareholder or by returning the completed registration form to Computershare A/S. The general meeting will be transmitted in full directly via webcast in Danish and English. Further information on the webcast and the general meeting is available at the company’s website, www.rockwool.com/group/agm. The webcast will only include the platform and...

Aspocomp Group Plc, Stock Exchange Release, March 14, 2024, at 9:15 a.m. Aspocomp Group Plc has published today its Remuneration Report for Governing Bodies 2023. The attached report is also available at the company’s website at www.aspocomp.com. For further information, please contact Mikko Montonen, President and CEO, tel. +358 20 775 6860, mikko.montonen(at)aspocomp.com. ASPOCOMP GROUP PLC Mikko Montonen President and CEO Aspocomp – heart of your technology A printed circuit board (PCB) is used for electrical interconnection and as a component assembly platform in electronic devices. Aspocomp provides PCB technology design, testing and logistics services over the entire lifecycle of a product. The company’s own production and extensive international partner network guarantee cost-effectiveness and reliable deliveries. Aspocomp’s...

TURKU, Finland and BOSTON, March 14, 2024 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, today announces it will host a virtual BEXMAB update event on Tuesday, March 19 at 11.00 EET/9am GMT, following the most recent data cut-off and scheduled analysis. Participants of the webcast will include Dr. Mika Kontro, MD, PhD, Associate Professor at the University of Helsinki and BEXMAB Principal Investigator; Dr. Maija Hollmen, PhD, Chief Scientific Officer at Faron, Dr Juho Jalkanen, MD, PhD, Chief Operating Officer at Faron and members of Faron’s senior management team. During the event the Company will discuss latest data...